Carregant...

SUN-046 Prevalence of Polycythaemia with Different Formulations of Testosterone Therapy in Transmasculine Individuals

Background: Masculinising hormone therapy with testosterone is used to align an individual’s physical characteristics with their gender identity. Testosterone therapy is typically administered via intramuscular or transdermal routes and polycythaemia is the most common adverse event. Aims: To compar...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Endocr Soc
Autors principals: Nolan, Brendan J, Leemaqz, Shalem Y, Ooi, Olivia, Cundill, Pauline, Silberstein, Nicholas, Locke, Peter, Grossmann, Mathis, Zajac, Jeffrey D, Cheung, Ada S
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7208758/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.865
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!